Kidney Research and Clinical Practice

Search

Page Path

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period: Hyuk Huh, Yong Soo Kim, Wookyung Chung et al.; Kidney Res Clin Pract. 2023;42(2):216-228. Published online January 13, 2023; DOI: https://doi.org/10.23876/j.krcp.22.024; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

MOST VIEWED MOST CITED

8,663	Recent advances in electron microscopy for the diagnosis and research of glomerular diseases
30,943	Uremic pruritus: pathophysiology, clinical presentation, and treatments
5,533	Updates in renal pathology
8,418	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
1,744	Zebra bodies in lupus nephritis after hydroxychloroquine therapy

Cited By 38	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 20	Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
Cited By 13	Intestinal microbiota and kidney diseases
Cited By 11	Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study
Cited By 10	Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr